The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dutasteride Market Research Report 2025
Synopsis
Dutasteride, sold under the brand name Avodart among others, is a medication used primarily to treat enlarged prostate in men.
The global Dutasteride market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dutasteride is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dutasteride is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dutasteride include GSK, Bionpharma, Rising Pharmaceuticals, Teva, Mylan, Zydus, Amneal Pharma, Apotex and Marksans Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dutasteride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dutasteride.
Report Scope
The Dutasteride market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dutasteride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dutasteride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Bionpharma
Rising Pharmaceuticals
Teva
Mylan
Zydus
Amneal Pharma
Apotex
Marksans Pharma
Breckenridge Pharmaceutical
Segment by Type
Type I
Type II
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dutasteride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dutasteride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Dutasteride, sold under the brand name Avodart among others, is a medication used primarily to treat enlarged prostate in men.
The global Dutasteride market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dutasteride is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dutasteride is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dutasteride include GSK, Bionpharma, Rising Pharmaceuticals, Teva, Mylan, Zydus, Amneal Pharma, Apotex and Marksans Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dutasteride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dutasteride.
Report Scope
The Dutasteride market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dutasteride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dutasteride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Bionpharma
Rising Pharmaceuticals
Teva
Mylan
Zydus
Amneal Pharma
Apotex
Marksans Pharma
Breckenridge Pharmaceutical
Segment by Type
Type I
Type II
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dutasteride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dutasteride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Dutasteride Market Overview
1.1 Product Overview and Scope of Dutasteride
1.2 Dutasteride Segment by Type
1.2.1 Global Dutasteride Market Value Comparison by Type (2024-2030)
1.2.2 Type I
1.2.3 Type II
1.3 Dutasteride Segment by Application
1.3.1 Global Dutasteride Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Dutasteride Market Size Estimates and Forecasts
1.4.1 Global Dutasteride Revenue 2019-2030
1.4.2 Global Dutasteride Sales 2019-2030
1.4.3 Global Dutasteride Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dutasteride Market Competition by Manufacturers
2.1 Global Dutasteride Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dutasteride Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dutasteride Average Price by Manufacturers (2019-2024)
2.4 Global Dutasteride Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dutasteride, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dutasteride, Product Type & Application
2.7 Dutasteride Market Competitive Situation and Trends
2.7.1 Dutasteride Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dutasteride Players Market Share by Revenue
2.7.3 Global Dutasteride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dutasteride Retrospective Market Scenario by Region
3.1 Global Dutasteride Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dutasteride Global Dutasteride Sales by Region: 2019-2030
3.2.1 Global Dutasteride Sales by Region: 2019-2024
3.2.2 Global Dutasteride Sales by Region: 2025-2030
3.3 Global Dutasteride Global Dutasteride Revenue by Region: 2019-2030
3.3.1 Global Dutasteride Revenue by Region: 2019-2024
3.3.2 Global Dutasteride Revenue by Region: 2025-2030
3.4 North America Dutasteride Market Facts & Figures by Country
3.4.1 North America Dutasteride Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dutasteride Sales by Country (2019-2030)
3.4.3 North America Dutasteride Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dutasteride Market Facts & Figures by Country
3.5.1 Europe Dutasteride Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dutasteride Sales by Country (2019-2030)
3.5.3 Europe Dutasteride Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dutasteride Market Facts & Figures by Country
3.6.1 Asia Pacific Dutasteride Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dutasteride Sales by Country (2019-2030)
3.6.3 Asia Pacific Dutasteride Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dutasteride Market Facts & Figures by Country
3.7.1 Latin America Dutasteride Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dutasteride Sales by Country (2019-2030)
3.7.3 Latin America Dutasteride Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dutasteride Market Facts & Figures by Country
3.8.1 Middle East and Africa Dutasteride Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dutasteride Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dutasteride Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dutasteride Sales by Type (2019-2030)
4.1.1 Global Dutasteride Sales by Type (2019-2024)
4.1.2 Global Dutasteride Sales by Type (2025-2030)
4.1.3 Global Dutasteride Sales Market Share by Type (2019-2030)
4.2 Global Dutasteride Revenue by Type (2019-2030)
4.2.1 Global Dutasteride Revenue by Type (2019-2024)
4.2.2 Global Dutasteride Revenue by Type (2025-2030)
4.2.3 Global Dutasteride Revenue Market Share by Type (2019-2030)
4.3 Global Dutasteride Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dutasteride Sales by Application (2019-2030)
5.1.1 Global Dutasteride Sales by Application (2019-2024)
5.1.2 Global Dutasteride Sales by Application (2025-2030)
5.1.3 Global Dutasteride Sales Market Share by Application (2019-2030)
5.2 Global Dutasteride Revenue by Application (2019-2030)
5.2.1 Global Dutasteride Revenue by Application (2019-2024)
5.2.2 Global Dutasteride Revenue by Application (2025-2030)
5.2.3 Global Dutasteride Revenue Market Share by Application (2019-2030)
5.3 Global Dutasteride Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Dutasteride Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Dutasteride Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Bionpharma
6.2.1 Bionpharma Corporation Information
6.2.2 Bionpharma Description and Business Overview
6.2.3 Bionpharma Dutasteride Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bionpharma Dutasteride Product Portfolio
6.2.5 Bionpharma Recent Developments/Updates
6.3 Rising Pharmaceuticals
6.3.1 Rising Pharmaceuticals Corporation Information
6.3.2 Rising Pharmaceuticals Description and Business Overview
6.3.3 Rising Pharmaceuticals Dutasteride Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Rising Pharmaceuticals Dutasteride Product Portfolio
6.3.5 Rising Pharmaceuticals Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Dutasteride Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Dutasteride Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Dutasteride Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Dutasteride Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Zydus
6.6.1 Zydus Corporation Information
6.6.2 Zydus Description and Business Overview
6.6.3 Zydus Dutasteride Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Zydus Dutasteride Product Portfolio
6.6.5 Zydus Recent Developments/Updates
6.7 Amneal Pharma
6.6.1 Amneal Pharma Corporation Information
6.6.2 Amneal Pharma Description and Business Overview
6.6.3 Amneal Pharma Dutasteride Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amneal Pharma Dutasteride Product Portfolio
6.7.5 Amneal Pharma Recent Developments/Updates
6.8 Apotex
6.8.1 Apotex Corporation Information
6.8.2 Apotex Description and Business Overview
6.8.3 Apotex Dutasteride Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Apotex Dutasteride Product Portfolio
6.8.5 Apotex Recent Developments/Updates
6.9 Marksans Pharma
6.9.1 Marksans Pharma Corporation Information
6.9.2 Marksans Pharma Description and Business Overview
6.9.3 Marksans Pharma Dutasteride Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Marksans Pharma Dutasteride Product Portfolio
6.9.5 Marksans Pharma Recent Developments/Updates
6.10 Breckenridge Pharmaceutical
6.10.1 Breckenridge Pharmaceutical Corporation Information
6.10.2 Breckenridge Pharmaceutical Description and Business Overview
6.10.3 Breckenridge Pharmaceutical Dutasteride Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Breckenridge Pharmaceutical Dutasteride Product Portfolio
6.10.5 Breckenridge Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dutasteride Industry Chain Analysis
7.2 Dutasteride Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dutasteride Production Mode & Process
7.4 Dutasteride Sales and Marketing
7.4.1 Dutasteride Sales Channels
7.4.2 Dutasteride Distributors
7.5 Dutasteride Customers
8 Dutasteride Market Dynamics
8.1 Dutasteride Industry Trends
8.2 Dutasteride Market Drivers
8.3 Dutasteride Market Challenges
8.4 Dutasteride Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
